191 related articles for article (PubMed ID: 36581998)
1. RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer.
Yang H; Xue M; Su P; Zhou Y; Li X; Li Z; Xia Y; Zhang C; Fu M; Zheng X; Luo G; Wei T; Wang X; Ding Y; Zhu J; Zhuang T
J Exp Clin Cancer Res; 2022 Dec; 41(1):364. PubMed ID: 36581998
[TBL] [Abstract][Full Text] [Related]
2. RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis.
Li Z; Su P; Ding Y; Gao H; Yang H; Li X; Yang X; Xia Y; Zhang C; Fu M; Wang D; Zhang Y; Zhuo S; Zhu J; Zhuang T
Cell Commun Signal; 2022 Oct; 20(1):164. PubMed ID: 36280829
[TBL] [Abstract][Full Text] [Related]
3. ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.
Liu Y; Su P; Zhao W; Li X; Yang X; Fan J; Yang H; Yan C; Mao L; Ding Y; Zhu J; Niu Z; Zhuang T
Cancer Sci; 2021 Jul; 112(7):2714-2727. PubMed ID: 33939216
[TBL] [Abstract][Full Text] [Related]
4. RNF181 modulates Hippo signaling and triple negative breast cancer progression.
Zhou R; Ding Y; Xue M; Xiong B; Zhuang T
Cancer Cell Int; 2020; 20():291. PubMed ID: 32655323
[TBL] [Abstract][Full Text] [Related]
5. UBR5 promotes tumor immune evasion through enhancing IFN-γ-induced
Wu B; Song M; Dong Q; Xiang G; Li J; Ma X; Wei F
Theranostics; 2022; 12(11):5086-5102. PubMed ID: 35836797
[No Abstract] [Full Text] [Related]
6. Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187.
Wang Z; Kong Q; Su P; Duan M; Xue M; Li X; Tang J; Gao Z; Wang B; Li Z; Liu Y; Yang X; Cao R; Song T; Wang K; Cai Y; Wu D; Li J; Wu G; Guled AM; Zhu J; Yan C; Zhuang T
Oncogenesis; 2020 Mar; 9(3):36. PubMed ID: 32198343
[TBL] [Abstract][Full Text] [Related]
7. p53 downregulates PD-L1 expression via miR-34a to inhibit the growth of triple-negative breast cancer cells: a potential clinical immunotherapeutic target.
Deng S; Wang M; Wang C; Zeng Y; Qin X; Tan Y; Liang B; Cao Y
Mol Biol Rep; 2023 Jan; 50(1):577-587. PubMed ID: 36352176
[TBL] [Abstract][Full Text] [Related]
8. [Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP].
Ou HL; Wu H; Ren YL; Si Y; Duan ZQ; Liu XW
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4483-4492. PubMed ID: 37802875
[TBL] [Abstract][Full Text] [Related]
9. RING finger protein 31 promotes p53 degradation in breast cancer cells.
Zhu J; Zhao C; Zhuang T; Jonsson P; Sinha I; Williams C; Strömblad S; Dahlman-Wright K
Oncogene; 2016 Apr; 35(15):1955-64. PubMed ID: 26148235
[TBL] [Abstract][Full Text] [Related]
10. Autophagy promotes triple negative breast cancer metastasis via YAP nuclear localization.
Chen W; Bai Y; Patel C; Geng F
Biochem Biophys Res Commun; 2019 Dec; 520(2):263-268. PubMed ID: 31590917
[TBL] [Abstract][Full Text] [Related]
11. PD-L1-mediated immune evasion in triple-negative breast cancer is linked to the loss of ZNF652.
Liu Y; Peng Y; Du W; Yu C; Peng Z; Qin L; Ma Y; Wu X; Peng Y; Cheng X; Xia L; Fa H; Wu Y; Sun L; Liu J; Liu Z; Shang Y; Wang S; Liang J
Cell Rep; 2023 Nov; 42(11):113343. PubMed ID: 37906592
[TBL] [Abstract][Full Text] [Related]
12. Syntenin1/MDA-9 (SDCBP) induces immune evasion in triple-negative breast cancer by upregulating PD-L1.
Liu J; Yang Y; Wang H; Wang B; Zhao K; Jiang W; Bai W; Liu J; Yin J
Breast Cancer Res Treat; 2018 Sep; 171(2):345-357. PubMed ID: 29845474
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
14. YAP transduction drives triple-negative breast cancer aggressiveness through modulating the EGFR‒AKT axis in patient-derived xenograft cells.
Parambil ST; Thankayyan SKR; Antony GR; Littleflower AB; Augustine P; Somanathan T; Subhadradevi L
Med Oncol; 2023 Apr; 40(5):137. PubMed ID: 37014473
[TBL] [Abstract][Full Text] [Related]
15. HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway.
Xu J; Fang X; Long L; Wang S; Qian S; Lyu J
Cancer Biol Ther; 2021 Jan; 22(1):5-11. PubMed ID: 33307962
[TBL] [Abstract][Full Text] [Related]
16. Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states.
Sulaiman A; McGarry S; Li L; Jia D; Ooi S; Addison C; Dimitroulakos J; Arnaout A; Nessim C; Yao Z; Ji G; Song H; Gadde S; Li X; Wang L
Mol Oncol; 2018 Apr; 12(4):423-440. PubMed ID: 29316250
[TBL] [Abstract][Full Text] [Related]
17. The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.
Zhu J; Zhao C; Kharman-Biz A; Zhuang T; Jonsson P; Liang N; Williams C; Lin CY; Qiao Y; Zendehdel K; Strömblad S; Treuter E; Dahlman-Wright K
Oncogene; 2014 Aug; 33(34):4340-51. PubMed ID: 24441041
[TBL] [Abstract][Full Text] [Related]
18. SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis.
Jiang K; Liu P; Xu H; Liang D; Fang K; Du S; Cheng W; Ye L; Liu T; Zhang X; Gong P; Shao S; Wang Y; Meng S
Oncogene; 2020 Jul; 39(27):5015-5030. PubMed ID: 32523092
[TBL] [Abstract][Full Text] [Related]
19. A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery.
Shadbad MA; Safaei S; Brunetti O; Derakhshani A; Lotfinejad P; Mokhtarzadeh A; Hemmat N; Racanelli V; Solimando AG; Argentiero A; Silvestris N; Baradaran B
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440380
[TBL] [Abstract][Full Text] [Related]
20. GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cells.
Deng Q; Jiang G; Wu Y; Li J; Liang W; Chen L; Su Q; Li W; Du J; Wong CKC; Chen Z; Wang H
J Hazard Mater; 2018 Aug; 355():1-9. PubMed ID: 29758456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]